OBJECTIVE: To determine whether quantitative measure of magnetic resonance imaging data from patients with the inherited leukodystrophy, Pelizaeus-Merzbacher disease (PMD) correlates with clinical severity or progression. METHODS: In our current work we have analyzed the clinical phenotypes and MRI scans of 51 male patients with PMD and 10 female carriers for whom the PLP1 genotype had been determined. In addition, we developed a 32-point functional disability scoring (FDS) system for PMD, and validated it for inter-rater reliability. Using conventional T1- and T2-weighted MRI images of the whole brain, we measured white matter and total brain volume (WMV and TBV), inter-caudate ratio (ICR), and corpus callosum area. RESULTS: There was a significant positive correlation of FDS with white matter fraction (WMV/TBV) and corpus callosum area. Also, when applying a median split based on FDS, patients with lower FDS showed reduced white matter fraction and corpus callosum area, and increased ICR compared to patients with relatively higher FDS, regardless of age. CONCLUSION: Although this patient population is heterogeneous, with multiple genetic and molecular mechanisms causing PMD, these data imply that white matter atrophy is a major pathological determinant of the clinical disability in most patients. Development of reliable non-invasive quantitative biomarkers of disease activity would be useful not only for following the natural history of the disease, but also raising the potential for evaluating future therapies.
OBJECTIVE: To determine whether quantitative measure of magnetic resonance imaging data from patients with the inherited leukodystrophy, Pelizaeus-Merzbacher disease (PMD) correlates with clinical severity or progression. METHODS: In our current work we have analyzed the clinical phenotypes and MRI scans of 51 male patients with PMD and 10 female carriers for whom the PLP1 genotype had been determined. In addition, we developed a 32-point functional disability scoring (FDS) system for PMD, and validated it for inter-rater reliability. Using conventional T1- and T2-weighted MRI images of the whole brain, we measured white matter and total brain volume (WMV and TBV), inter-caudate ratio (ICR), and corpus callosum area. RESULTS: There was a significant positive correlation of FDS with white matter fraction (WMV/TBV) and corpus callosum area. Also, when applying a median split based on FDS, patients with lower FDS showed reduced white matter fraction and corpus callosum area, and increased ICR compared to patients with relatively higher FDS, regardless of age. CONCLUSION: Although this patient population is heterogeneous, with multiple genetic and molecular mechanisms causing PMD, these data imply that white matter atrophy is a major pathological determinant of the clinical disability in most patients. Development of reliable non-invasive quantitative biomarkers of disease activity would be useful not only for following the natural history of the disease, but also raising the potential for evaluating future therapies.
Authors: Laura A Harsan; Patrick Poulet; Blandine Guignard; Nathalie Parizel; Robert P Skoff; M Said Ghandour Journal: J Neurosci Res Date: 2007-04 Impact factor: 4.164
Authors: I Griffiths; M Klugmann; T Anderson; D Yool; C Thomson; M H Schwab; A Schneider; F Zimmermann; M McCulloch; N Nadon; K A Nave Journal: Science Date: 1998-06-05 Impact factor: 47.728
Authors: H Butzkueven; S C Kolbe; D J Jolley; J Y Brown; M J Cook; I A F van der Mei; P S Groom; J Carey; J Eckholdt; J P Rubio; B V Taylor; P J Mitchell; G F Egan; T J Kilpatrick Journal: J Clin Neurosci Date: 2008-02 Impact factor: 1.961
Authors: Adam M Brickman; Lawrence S Honig; Nikolaos Scarmeas; Oksana Tatarina; Linda Sanders; Marilyn S Albert; Jason Brandt; Deborah Blacker; Yaakov Stern Journal: Arch Neurol Date: 2008-09
Authors: Zachary S Nevin; Daniel C Factor; Robert T Karl; Panagiotis Douvaras; Jeremy Laukka; Martha S Windrem; Steven A Goldman; Valentina Fossati; Grace M Hobson; Paul J Tesar Journal: Am J Hum Genet Date: 2017-03-30 Impact factor: 11.025
Authors: Thierry Morlet; Kyoko Nagao; S Charles Bean; Sara E Mora; Sarah E Hopkins; Grace M Hobson Journal: J Neurol Date: 2018-05-03 Impact factor: 4.849
Authors: Jennifer R Taube; Karen Sperle; Linda Banser; Pavel Seeman; Barbra Charina V Cavan; James Y Garbern; Grace M Hobson Journal: Hum Mol Genet Date: 2014-06-01 Impact factor: 6.150
Authors: Parand Zarekiani; Marjolein Breur; Nicole I Wolf; Helga E de Vries; Marjo S van der Knaap; Marianna Bugiani Journal: Acta Neuropathol Commun Date: 2021-06-03 Impact factor: 7.801
Authors: Sietske H Kevelam; Jennifer R Taube; Rosalina M L van Spaendonk; Enrico Bertini; Karen Sperle; Mark Tarnopolsky; Davide Tonduti; Enza Maria Valente; Lorena Travaglini; Erik A Sistermans; Geneviève Bernard; Coriene E Catsman-Berrevoets; Clara D M van Karnebeek; John R Østergaard; Richard L Friederich; Mahmoud Fawzi Elsaid; Jolanda H Schieving; Maja Tarailo-Graovac; Simona Orcesi; Marjan E Steenweg; Carola G M van Berkel; Quinten Waisfisz; Truus E M Abbink; Marjo S van der Knaap; Grace M Hobson; Nicole I Wolf Journal: Ann Clin Transl Neurol Date: 2015-05-01 Impact factor: 4.511